|
1
|
Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells.
|
Nature
|
2010
|
6.13
|
|
2
|
Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme.
|
Clin Cancer Res
|
2008
|
2.52
|
|
3
|
Targeted therapy with bevacizumab and erlotinib tailored to the molecular profile of patients with recurrent glioblastoma. Preliminary experience.
|
Acta Neurochir (Wien)
|
2012
|
1.99
|
|
4
|
Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin.
|
J Clin Oncol
|
2010
|
1.66
|
|
5
|
Distribution, function, and prognostic value of cytotoxic T lymphocytes in follicular lymphoma: a 3-D tissue-imaging study.
|
Blood
|
2011
|
1.62
|
|
6
|
Inhibition of telomerase in the endothelial cells disrupts tumor angiogenesis in glioblastoma xenografts.
|
Int J Cancer
|
2008
|
1.55
|
|
7
|
Molecular analysis of immunoglobulin variable genes in human immunodeficiency virus-related non-Hodgkin's lymphoma reveals implications for disease pathogenesis and histogenesis.
|
Haematologica
|
2008
|
1.54
|
|
8
|
Mutations of the BIK gene in human peripheral B-cell lymphomas.
|
Genes Chromosomes Cancer
|
2003
|
1.50
|
|
9
|
Anemia in diffuse large B-cell non-Hodgkin lymphoma: the role of interleukin-6, hepcidin and erythropoietin.
|
Leuk Lymphoma
|
2013
|
1.47
|
|
10
|
Primary plasma cell leukemia followed by testicular plasmacytoma.
|
Int J Hematol
|
2011
|
1.44
|
|
11
|
Endothelial progenitor cells in HIV-positive patients: what are we talking about?
|
J Acquir Immune Defic Syndr
|
2013
|
1.42
|
|
12
|
Chordoma of the skull base: predictors of tumor recurrence.
|
J Neurosurg
|
2003
|
1.24
|
|
13
|
Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutation.
|
Blood
|
2007
|
1.19
|
|
14
|
Role of the life span determinant P66(shcA) in ethanol-induced liver damage.
|
Lab Invest
|
2008
|
1.15
|
|
15
|
Hereditary thrombocytosis caused by MPLSer505Asn is associated with a high thrombotic risk, splenomegaly and progression to bone marrow fibrosis.
|
Haematologica
|
2009
|
1.15
|
|
16
|
Molecular histogenesis of plasmablastic lymphoma of the oral cavity.
|
Br J Haematol
|
2002
|
1.10
|
|
17
|
Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis.
|
Cancer
|
2010
|
1.07
|
|
18
|
Possible involvement of hMLH1, p16(INK4a) and PTEN in the malignant transformation of endometriosis.
|
Int J Cancer
|
2002
|
1.07
|
|
19
|
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior.
|
Prostate
|
2010
|
1.06
|
|
20
|
Can a gene-expression classifier with high negative predictive value solve the indeterminate thyroid fine-needle aspiration dilemma?
|
Cancer Cytopathol
|
2013
|
1.06
|
|
21
|
Is morphology alone able to predict BRAF-mutated malignancies on thyroid FNAC?
|
Virchows Arch
|
2014
|
1.06
|
|
22
|
Endothelial progenitor cells are clonal and exhibit the JAK2(V617F) mutation in a subset of thrombotic patients with Ph-negative myeloproliferative neoplasms.
|
Blood
|
2011
|
1.05
|
|
23
|
A novel heterozygous HIF2AM535I mutation reinforces the role of oxygen sensing pathway disturbances in the pathogenesis of familial erythrocytosis.
|
Haematologica
|
2008
|
1.04
|
|
24
|
Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer?
|
Clin Colorectal Cancer
|
2011
|
1.02
|
|
25
|
Telomerase inhibition impairs tumor growth in glioblastoma xenografts.
|
Neurol Res
|
2006
|
0.99
|
|
26
|
Thrombocythemia and polycythemia in patients younger than 20 years at diagnosis: clinical and biologic features, treatment, and long-term outcome.
|
Blood
|
2012
|
0.98
|
|
27
|
Establishing tumor cell lines from aggressive telomerase-positive chordomas of the skull base. Technical note.
|
J Neurosurg
|
2006
|
0.97
|
|
28
|
Genome wide DNA-profiling of HIV-related B-cell lymphomas.
|
Br J Haematol
|
2009
|
0.97
|
|
29
|
Expression of EGFRvIII in glioblastoma: prognostic significance revisited.
|
Neoplasia
|
2011
|
0.97
|
|
30
|
Prognostic relevance of SOCS3 hypermethylation in patients with glioblastoma multiforme.
|
Int J Cancer
|
2008
|
0.96
|
|
31
|
BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma.
|
Cancer Cytopathol
|
2012
|
0.93
|
|
32
|
The transient receptor potential vanilloid-2 cation channel impairs glioblastoma stem-like cell proliferation and promotes differentiation.
|
Int J Cancer
|
2012
|
0.93
|
|
33
|
Congenital tumors of the retrorectal space in the adult: report of two cases and review of the literature.
|
Tumori
|
2008
|
0.92
|
|
34
|
Paediatric Kikuchi-Fujimoto disease: a benign cause of fever and lymphadenopathy.
|
Pediatr Blood Cancer
|
2008
|
0.91
|
|
35
|
Soft tissue non-Hodgkin lymphoma of shoulder in a HIV patient: a report of a case and review of the literature.
|
World J Surg Oncol
|
2008
|
0.91
|
|
36
|
Characterization of variants in the promoter of EBV gene BZLF1 in normal donors, HIV-positive patients and in AIDS-related lymphomas.
|
J Infect
|
2006
|
0.89
|
|
37
|
Epigenetic alteration of SOCS family members is a possible pathogenetic mechanism in JAK2 wild type myeloproliferative diseases.
|
Int J Cancer
|
2008
|
0.89
|
|
38
|
Prognostic relevance of c-Myc and BMI1 expression in patients with glioblastoma.
|
Am J Clin Pathol
|
2012
|
0.89
|
|
39
|
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma.
|
Leuk Res
|
2009
|
0.88
|
|
40
|
Role of PTEN in gastrointestinal stromal tumor progression.
|
Arch Pathol Lab Med
|
2004
|
0.87
|
|
41
|
Mutations of CD79A, CD79B and EZH2 genes in immunodeficiency-related non-Hodgkin lymphomas.
|
Br J Haematol
|
2011
|
0.87
|
|
42
|
Glutathione-S-transferase genotypes influence prognosis in follicular non-Hodgkin's Lymphoma.
|
Leuk Lymphoma
|
2007
|
0.87
|
|
43
|
Epigenetic silencing of Id4 identifies a glioblastoma subgroup with a better prognosis as a consequence of an inhibition of angiogenesis.
|
Cancer
|
2012
|
0.86
|
|
44
|
Detrimental clinical interaction between ritonavir-boosted protease inhibitors and vinblastine in HIV-infected patients with Hodgkin's lymphoma.
|
AIDS
|
2010
|
0.86
|
|
45
|
Characterization of cell death pathways in human immunodeficiency virus-associated encephalitis.
|
Am J Pathol
|
2005
|
0.85
|
|
46
|
Influence of local environment on the differentiation of neural stem cells engrafted onto the injured spinal cord.
|
Neurol Res
|
2006
|
0.84
|
|
47
|
Endoscopic ultrasound-guided fine-needle aspiration with liquid-based cytologic preparation in the diagnosis of primary pancreatic lymphoma.
|
Pancreas
|
2010
|
0.84
|
|
48
|
Childhood CD4+/CD56+ hematodermic neoplasm: case report and review of the literature.
|
Haematologica
|
2006
|
0.84
|
|
49
|
Diagnostic and prognostic value of immunocytochemistry and BRAF mutation analysis on liquid-based biopsies of thyroid neoplasms suspicious for carcinoma.
|
Eur J Endocrinol
|
2013
|
0.84
|
|
50
|
Telomerase inhibition by stable RNA interference impairs tumor growth and angiogenesis in glioblastoma xenografts.
|
Int J Cancer
|
2006
|
0.82
|
|
51
|
Glioblastoma induces vascular endothelial cells to express telomerase in vitro.
|
Cancer Res
|
2003
|
0.82
|
|
52
|
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma.
|
Leuk Lymphoma
|
2011
|
0.81
|
|
53
|
Characterization of Epstein-Barr virus genotype in AIDS-related non-Hodgkin's lymphoma.
|
AIDS Res Hum Retroviruses
|
2002
|
0.81
|
|
54
|
Dysregulated expression of Bcl-xL in CD34+ cells isolated from patients with refractory anemia with excess of blasts during megakaryocytic differentiation.
|
Haematologica
|
2002
|
0.81
|
|
55
|
Association of the OCTN1/1672T variant with increased risk for colorectal cancer in young individuals and ulcerative colitis patients.
|
Inflamm Bowel Dis
|
2011
|
0.80
|
|
56
|
Childhood polycythemia vera and essential thrombocythemia: does their pathogenesis overlap with that of adult patients?
|
Haematologica
|
2008
|
0.80
|
|
57
|
Cervical extramedullary lymphomatoid granulomatosis.
|
J Clin Neurosci
|
2011
|
0.80
|
|
58
|
Transferrin receptor 2 is frequently and highly expressed in glioblastomas.
|
Transl Oncol
|
2010
|
0.80
|
|
59
|
Systemic granulomatous reaction secondary to treatment of bladder cancer with bacillus calmette-guerin.
|
Mediterr J Hematol Infect Dis
|
2012
|
0.79
|
|
60
|
Overexpression of the polycythemia rubra vera-1 gene in essential thrombocythemia.
|
J Clin Oncol
|
2002
|
0.79
|
|
61
|
Alterations of negative regulators of cytokine signalling in immunodeficiency-related non-Hodgkin lymphoma.
|
Hematol Oncol
|
2012
|
0.78
|
|
62
|
Analysis of immunocytochemical and molecular BRAF expression in thyroid carcinomas: a cytohistologic institutional experience.
|
Cancer Cytopathol
|
2014
|
0.78
|
|
63
|
Effect of antiviral therapy on pro-angiogenic hematopoietic and endothelial progenitor cells in HIV-infected people.
|
Thromb Res
|
2013
|
0.78
|
|
64
|
Morphological parameters able to predict BRAF(V600E) -mutated malignancies on thyroid fine-needle aspiration cytology: Our institutional experience.
|
Cancer Cytopathol
|
2014
|
0.77
|
|
65
|
In vitro and in vivo modulation of MDR1/P-glycoprotein in HIV-infected patients administered highly active antiretroviral therapy and liposomal doxorubicin.
|
J Acquir Immune Defic Syndr
|
2002
|
0.77
|
|
66
|
Combined Modality Treatment Including Methotrexate-Based Chemotherapy For Primary CENTRAL Nervous System Lymphoma: A Single Institution Experience.
|
Mediterr J Hematol Infect Dis
|
2009
|
0.77
|
|
67
|
Small lymphocytic lymphoma in a patient with Fabry disease.
|
Leuk Lymphoma
|
2012
|
0.77
|
|
68
|
Chemotherapy of skull base chordoma tailored on responsiveness of patient-derived tumor cells to rapamycin.
|
Neoplasia
|
2013
|
0.76
|
|
69
|
Patchy left-sided colitis: primary eosinophilic colitis or paraneoplastic syndrome?
|
Clin Gastroenterol Hepatol
|
2009
|
0.76
|
|
70
|
DAP-kinase hypermethylation in the bone marrow of patients with follicular lymphoma.
|
Haematologica
|
2006
|
0.76
|
|
71
|
Introducing mediterranean journal of hematology and infectious diseases.
|
Mediterr J Hematol Infect Dis
|
2009
|
0.75
|
|
72
|
Mantle cell lymphoma relapsing at the lymphedematous arm.
|
Mediterr J Hematol Infect Dis
|
2013
|
0.75
|
|
73
|
Primary pancreatic lymphoma in a patient with maturity onset diabetes of the young type 3.
|
Mediterr J Hematol Infect Dis
|
2012
|
0.75
|
|
74
|
Does "more" necessarily mean "better"?
|
Blood
|
2012
|
0.75
|
|
75
|
Blood and endothelial cells: together through thick and thin.
|
Blood
|
2013
|
0.75
|
|
76
|
Simultaneous presentation of Waldenstrom's macroglobulinemia and acute myeloid leukemia.
|
Haematologica
|
2002
|
0.75
|
|
77
|
Detection of ectopic thyroid remnants: a serious diagnostic dilemma. When molecular biology and immunohistochemistry can solve the problem.
|
Pathol Res Pract
|
2012
|
0.75
|
|
78
|
Extremely delayed falx metastasis from renal cell carcinoma.
|
Neurology
|
2007
|
0.75
|
|
79
|
[Retroperitoneal Castleman's disease. A report of two cases and analysis of the literature].
|
Chir Ital
|
2007
|
0.75
|
|
80
|
Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab.
|
J Clin Oncol
|
2008
|
0.75
|
|
81
|
Absence of structural mutations of the BAK gene in B cell lymphomas.
|
Haematologica
|
2002
|
0.75
|
|
82
|
Essential thrombocythemia as underlying cause of malabsorption syndrome.
|
Ann Hematol
|
2010
|
0.75
|
|
83
|
The expression pattern of c-mpl in megakaryocytes correlates with thrombotic risk in essential thrombocythemia.
|
Blood
|
2002
|
0.75
|
|
84
|
The mutant JAK2 allele burden in children with essential thrombocythemia.
|
Br J Haematol
|
2009
|
0.75
|